Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03490734 · ClinicalTrials.gov registry record · NA

Neurobehavioral Plasticity to Regular Sugar-Sweetened Beverage Intake: An fMRI Experiment

A NA study of Obesity and Weight Gain, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
160
Enrollment target
1
Study location

NCT03490734: Completed NA study of Obesity and Weight Gain, sponsored by University of North Carolina, Chapel Hill.

NCT03490734 is a NA study of Obesity and Weight Gain that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 160 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03490734, a NA study of Obesity and Weight Gain, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

The proposed project will examine the strength, specificity and persistence of neurobehavioral adaptions that occur in the initial period of repeated consumption of a branded sugar sweetened beverage (SSB).

Primary Outcome

The fMRI paradigm assesses evoked blood oxygen level dependent (BOLD) response to receipt of study beverages (sweet and unsweet) and a water solution, and logo-elicited anticipation of both beverages and water solution. The visual stimuli are two beverage logos, a water logo, and a fixation cross. Each logo (1 second) signals impending delivery of 3 mL of the associated juice/water over 6 seconds, with the fixation cross otherwise presented. A jitter ranging from 5 to 13 seconds follows each tri

Conditions Studied

Interventions

  • OTHER Water
  • DIETARY_SUPPLEMENT Black Cherry and Orange Flavored Beverage with added sugar
  • DIETARY_SUPPLEMENT Strawberry Kiwi &Lemonade Flavored Beverage with added sugar
  • DIETARY_SUPPLEMENT Black Cherry and Orange Flavored Beverage no added sugar
  • DIETARY_SUPPLEMENT Strawberry Kiwi & Lemonade Flavored Beverage no added sugar

Study Locations (1)

North Carolina

  • Mcgavran-Greenberg Hall - Chapel Hill

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2018-04-10
Est. Completion 2022-03-18
Phase NA

What the finished NCT03490734 record still lists

NCT03490734 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (80% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 5 interventions - of which Water is the first listed.

NCT03490734 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT03490734 about?

NCT03490734 is a clinical study titled "Neurobehavioral Plasticity to Regular Sugar-Sweetened Beverage Intake: An fMRI Experiment". The proposed project will examine the strength, specificity and persistence of neurobehavioral adaptions that occur in the initial period of repeated consumption of a branded sugar sweetened beverage (SSB).

What is the current status of trial NCT03490734?

This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2018-04-10. Estimated completion is 2022-03-18.

What conditions does trial NCT03490734 study?

This clinical trial studies the following conditions: Obesity, Weight Gain.

What interventions are being tested in trial NCT03490734?

The interventions under investigation include: Water (OTHER), Black Cherry and Orange Flavored Beverage with added sugar (DIETARY_SUPPLEMENT), Strawberry Kiwi &Lemonade Flavored Beverage with added sugar (DIETARY_SUPPLEMENT), Black Cherry and Orange Flavored Beverage no added sugar (DIETARY_SUPPLEMENT), Strawberry Kiwi & Lemonade Flavored Beverage no added sugar (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03490734?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03490734 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03490734's enrollment target sits among peer trials

160 359th of 1053 higher than 691 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00501826 · 160 participants · Phase 2

    Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

  • NCT00932139 · 160 participants · NA

    Effect of Electro-Acupuncture on Blood Pressure

  • NCT00992901 · 160 participants · Early Phase 1

    Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

  • NCT01515527 · 160 participants · Phase 2

    Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03490734, the US trial registry maintained by the National Library of Medicine. NCT03490734 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.